XML 42 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Basis of Presentation, Organization and Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
May 10, 2010
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2016
Ownership percentage   100.00%   100.00%    
Sales from continuing operations   $ 7,177,763 $ 5,426,147 $ 19,379,768 $ 16,716,487  
Excluded from the calculation of Diluted EPS (in shares)   145,750 844,250 512,750 486,000  
International [Member]            
Sales from continuing operations       $ 7,360,665 $ 7,391,559  
Accounts receivable   $ 762,000   762,000   $ 768,000
SonaCare Medical, LLC ("SonaCare") [Member]            
Proceeds from sale of intangible assets $ 5,800,000     1,504,788    
Earn-out percentage 7.00%          
Proceeds from sale of intangible assets $ 3,000,000          
Earn-out percentage 5.00%          
Proceeds from sale of intangible assets $ 5,800,000          
Royalty revenue   $ 250,000 $ 250,000      
SonaCare Medical, LLC ("SonaCare") [Member] | Minimum [Member]            
Royalty revenue $ 250,000          
Cicel (Beijing) Science and Tech Co. Ltd. ("Cicel") [Member]            
Sales from continuing operations       0 $ 1,337,277  
Percentage of continuing operations   10.00%     8.00%  
Accounts receivable   $ 369,463   369,463   0
Medtronic Minimally Invasive Therapies ("MMIT") [Member]            
Accounts receivable   953,000   953,000   $ 973,000
Medtronic Minimally Invasive Therapies ("MMIT") [Member] | License Agreement [Member]            
Royalty revenue   $ 953,235 $ 956,947 $ 2,838,487 $ 2,932,240